| Previous close | 96.22 |
| Open | 96.22 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 96.22 - 96.22 |
| 52-week range | 85.62 - 110.36 |
| Volume | |
| Avg. volume | 17 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Abbott (ABT) Gets FDA Nod for Two Glucose Monitoring Systems
Abbott's (ABT) glucose monitoring systems - Lingo and Libre Rio - based on Freestyle Libre technology, receive FDA clearance.
- Zacks
Abbott (ABT) Stock Sinks As Market Gains: Here's Why
Abbott (ABT) closed the most recent trading day at $105.81, moving -1.56% from the previous trading session.
- Investor's Business Daily
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
Abbott Laboratories gained U.S. clearance Monday for a pair of new CGMs. But Abbott stock fell a fraction at the close.
© 2024 Yahoo. All rights reserved.